Use of Abciximab for Mediation of Thromboembolic Complications of Endovascular Therapy

References

1. 1.↵
   Wallace RC, Furlan AJ, Moliterno DJ, Stevens GH, Masaryk TJ, Perl J II. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol 1997;18:1257-1260

   Abstract
2. 2.↵
   Tong FC, Cloft HJ, Joseph GJ, Samuels OB, Dion JE. Abciximab rescue in acute stent thrombosis. AJNR Am J Neuroradiol 2000;21:1750-1752

   Abstract/FREE Full Text
3. 3.↵
   Lempert TE, Malek AM, Halbach VV, Phatouros CC, Dowd CF, Higashida RT. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999;30:693-695

   FREE Full Text
4. 4.↵
   Samuels OB, Mohomed Y, Miller D, et al. Percutaneous transluminal angioplasty plus abciximab for vertebrobasilar stenosis. Presented at: American Society of Interventional and Therapeutic Neuroradiology meeting; January 1999
5. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601-609

   Abstract/FREE Full Text
6. 5.↵
   Henry P, Boughalem K, Rinaldi JP, et al. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation. Cathet Cardiovasc Diagn 1998;43:105-107

   PubMed
7. 6.↵
   Garbarz E, Farah B, Vuillemenot A, el al “Rescue” abciximab for complicated percutaneous transluminal coronary angioplasty. Am J Cardiol 1998;82:800-803

   CrossRefPubMedWeb of Science
8. 7.
   Muhlestein JB, Karagounis LA, Treehan S, Anderson JL. “Rescue” utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997;30:1729-1734

   CrossRefPubMedWeb of Science
9. 8.
   Haase KK, Mahrholdt H, Schroder S, et al. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty. Am Heart J 1999;137:234-240

   CrossRefPubMedWeb of Science
10. 9.
    Casserly IP, Hasdai D, Berger PB, Holmes DR Jr, Schwartz RS, Bell MR. Usefulness of abciximab for treatment of early coronary artery stent thrombosis. Am J Cardiol 1998;82:981-985

    CrossRefPubMedWeb of Science
11. 10.
    Rechavia E, Wurzel M. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery. Circulation 1998;98:1249-1250

    FREE Full Text
12. 11.↵
    Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720-2732

    Abstract/FREE Full Text
13. 12.↵
    Rerkpattanapipat P, Kotler MN, Yazdanfar S. Images in cardiovascular medicine; rapid dissolution of massive intracoronary thrombosis with platelet glycoprotein IIb/IIIa receptor inhibitor. Circulation 1999;99:2965

    FREE Full Text
14. 13.
    Bailey SR, O'Leary E, Chilton R. Angioscopic evaluation of site-specific administration of ReoPro. Cathet Cardiovasc Diagn 1997;42:181-184

    CrossRefPubMedWeb of Science
15. 14.
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 1999;282:2003-2011

    CrossRefPubMedWeb of Science